Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

(1R,2S) 6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-(1-naphthyl)-beta-phenyl-3-quinolineethanol

EU orphan designation number: EU/3/05/314   
Active ingredient: (1R,2S) 6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-(1-naphthyl)-beta-phenyl-3-quinolineethanol
Indication: Treatment of tuberculosis
Sponsor: Janssen-Cilag International NV
Turnhoutseweg 30, B-2340 Beerse, BelgiŽ
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Sirturo on 05/03/2014 with the number EU/1/13/901

   Public summary of scientific opinion     EPAR

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2005 Centralised Orphan - Designation EMEA/OD/024/05 (2005)3337 of 26/08/2005
09/12/2008 Centralised Orphan - Transfer of orphan designation EMEA/OD/024/05/T/01 (2008)8161 of 04/12/2008
17/07/2012 Other procedure EMEA/OD/024/05
03/08/2012 Other procedure EMEA/OD/024/05
10/09/2012 Centralised Orphan - Transfer of orphan designation EMEA/OD/024/05/T/02 (2012)6285 of 06/09/2012